Login
Sign up
LOG IN
SIGN UP
Home
Publications
General publications
Medical publications
discussions
General discussions
MEDICAL DISCUSSIONS
Topics
General topics
Medical topics
Home
Publications
General publications
Medical publications
discussions
General discussions
MEDICAL DISCUSSIONS
Topics
General topics
Medical topics
Pharma Professional
Sagar Shashikant Pawar
India
Partner, KPMG
Follow
KPMG
Mumbai
, India
0
Followers
0
Following
Pharma Professional
Sagar Shashikant Pawar
0
Followers
0
Following
India
Partner, KPMG
Follow
0
Followers
0
profile.followed
My Practices
KPMG
Mumbai
, India
All
About
Discussions
Cоntacts
If you log in your invitations for discussions will appear here.
Login
Registration
149
Participants
11
Opinions
New Growth Drivers for Indian Pharma companies
Discussion
7 Likes
149
Participants
11
Opinions
127
Participants
7
Opinions
How to Launch New Products in the Current Environment? Role of Digital in Launching New Products
Discussion
6 Likes
127
Participants
7
Opinions
92
Participants
2
Opinions
Women Leaders in Healthcare
Discussion
5 Likes
92
Participants
2
Opinions
149
Participants
16
Opinions
Being Digital: Vanity to Value Creation?
Discussion
9 Likes
149
Participants
16
Opinions
87
Participants
2
Opinions
Digital Competence Certification by DEPA
Discussion
3 Likes
87
Participants
2
Opinions
167
Participants
15
Opinions
Sales Force Strategy in the Digital World
Discussion
9 Likes
167
Participants
15
Opinions
155
Participants
15
Opinions
Building Meaningful Brands
Discussion
5 Likes
155
Participants
15
Opinions
238
Participants
13
Opinions
The Covid19 Crisis and Leadership Imperative for Indian Pharma CEOs
Discussion
15 Likes
238
Participants
13
Opinions
124
Participants
26
Opinions
The Pharma Dialogue - The One Who Tells the Best Story Wins
Discussion
8 Likes
124
Participants
26
Opinions
156
Participants
10
Opinions
Beating Digital Darwinism - Indian Pharma Needs a New Robust Strategy Not a Digital Strategy
Discussion
7 Likes
156
Participants
10
Opinions
226
Participants
20
Opinions
Lessons for Indian Pharma from Case Studies from EU
Discussion
5 Likes
226
Participants
20
Opinions